Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese

Neurobiology of Aging

Volumn 29, Issue 6, 2008, Pages 856-860

  Ma, Suk Ling ^a   Tang, Nelson Leung Sang ^a,b   Zhang, Ya Ping ^c   Ji, Lin dan ^c,d   Tam, Cindy Woon Chi ^a   Lui, Victor Wing Cheong ^a   Chiu, Helen Fung Kum ^a,e   Lam, Linda Chiu Wa ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c KUNMING INSTITUTE OF ZOOLOGY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e Jockey Club Centre for Positive Ageing   (Hong Kong)

Author keywords

Alzheimer's disease; Chinese; Polymorphisms; PTGS2

Indexed keywords

PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 2;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHINA; CYCLOOXYGENASE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 42649138585     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.12.011     Document Type: Article

References (31)

1. Abdullah L., Ait-Ghezala G., Crawford F., Crowell T.A., Barker W.W., Duara R., and Mullan M. The cyclooxygenase 2 -765C promoter allele is a protective factor for Alzheimer's disease. Neurosci. Lett. 395 3 (2005) 240-243
2. Almer G., Guegan C., Teismann P., Naini A., Rosoklija G., Hays A.P., Chen C., and Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 49 2 (2001) 176-185
3. Chan A.S., Choi M.K., and Salmon D.P. The effects of age, education, and gender on the Mattis Dementia Rating Scale performance of elderly Chinese and American individuals. J. Gerontol. B Psychol. Sci. Soc. Sci. 56 (2001) 356-363
4. Chiu H.F.K., Lee H.C., Chung W.S., and Kwong P.K. Reliability and validity of the Cantonese version of the Min-Mental State Examination-a preliminary study. J. Hong Kong College Psychiatrists 4 Suppl. 2 (1994) 25-28
5. Collins J.S., Perry R.T., Watson Jr. B., Harrell L.E., Acton R.T., Blacker D., Albert M.S., Tanzi R.E., Bassett S.S., McInnis M.G., Campbell R.D., and Go R.C. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am. J. Med. Genet. 96 6 (2000) 823-830
6. Ho L., Luterman J.D., Aisen P.S., Pasinetti G.M., Montine T.J., and Morrow J.D. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 55 2 (2000) 323
7. Ho L., Purohit D., Haroutunian V., Luterman J.D., Willis F., Naslund J., Buxbaum J.D., Mohs R.C., Aisen P.S., and Pasinetti G.M. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 58 3 (2001) 487-492
8. Hoozemans J.J., and O'Banion M.K. The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs. Curr. Drug Targets CNS Neurol. Disord. 4 3 (2005) 307-315
9. in t' Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M., and Stricker B.H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345 21 (2001) 1515-1521
10. Langsenlehner U., Yazdani-Biuki B., Eder T., Renner W., Wascher T.C., Paulweber B., Weitzer W., Samonigg H., and Krippl P. The cyclooxygenase-2 (PTGS2) 8473 T>C polymorphism is associated with breast cancer risk. Clin. Cancer Res. 12 4 (2006) 1392-1394
11. Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C., Casadei V., and Grimaldi L.M. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. J. Neuroimmunol. 103 1 (2000) 97-102
12. Lio D., Licastro F., Scola L., Chiappelli M., Grimaldi L.M., Crivello A., Colonna-Romano G., Candore G., Franceschi C., and Caruso C. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immunol. 4 3 (2003) 234-238
13. Liu F., Pan K., Zhang X., Zhang Y., Zhang L., Ma J., Dong C., Shen L., Li J., Deng D., Lin D., and You W. Genetic variants in cyclooxygenase-2: expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 130 7 (2006) 1975-1984
14. Ma S.L., Tang N.L., Lam L.C., and Chiu H.F. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol. Aging 26 7 (2005) 1005-1010
15. Ma S.L., Tang N.L., Lam L.C., and Chiu H.F. Association between tumor necrosis factor-alpha promoter polymorphism and Alzheimer's disease. Neurology 62 2 (2004) 307-309
16. McGeer P.L., Schulzer M., and McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47 2 (1996) 425-432
17. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M., and Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 202 1-2 (2002) 13-23
18. Muller N., Strassnig M., Schwarz M.J., Ulmschneider M., and Riedel M. COX-2 inhibitors as adjunctive therapy in schizophrenia. Exp. Opin. Invest. Drugs 13 8 (2004) 1033-1044
19. Packer B.R., Yeager M., Staats B., Welch R., Crenshaw A., Kiley M., Eckert A., Beerman M., Miller E., Bergen A., Rothman N., Strausberg R., and Chanock S.J. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res. 32 Database issue (2004) D528-D532
20. Papafili A., Hill M.R., Brull D.J., McAnulty R.J., Marshall R.P., Humphries S.E., and Laurent G.J. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler. Thromb. Vasc. Biol. 22 10 (2002) 1631-1636
21. Park J.M., Choi J.E., Chae M.H., Lee W.K., Cha S.I., Son J.W., Kim C.H., Kam S., Kang Y.M., Jung T.H., and Park J.Y. Relationship between cyclooxygenase 8473 T>C polymorphism and risk of lung cancer: a case-control study. BMC Cancer 6 1 (2006) 70
22. Pasinetti G.M., and Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87 2 (1998) 319-324
23. Sakoda L.C., Gao Y.T., Chen B.E., Chen J., Rosenberg P.S., Rashid A., Deng J., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Cohen-Webb H., Yeager M., Welch R., Chanock S., Fraumeni Jr. J.F., and Hsing A.W. Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27 6 (2006) 1251-1256
24. Shibata N., Ohnuma T., Takahashi T., Baba H., Ishizuka T., Ohtsuka M., Ueki A., Nagao M., and Arai H. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am. J. Med. Genet. 114 4 (2002) 436-439
25. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
26. Sorensen M., Autrup H., Tjonneland A., Overvad K., and Raaschou-Nielsen O. A genetic polymorphism in prostaglandin synthase 2 (8473, T→C) and the risk of lung cancer. Cancer Lett. 226 1 (2005) 49-54
27. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 4 (2001) 978-989
28. Tang N.L., Pharoah P.D., Ma S.L., and Easton D.F. Evaluation of an algorithm of tagging SNPs selection by linkage disequilibrium. Clin. Biochem. 39 3 (2006) 240-243
29. Teismann P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., Vila M., Jackson-Lewis V., and Przedborski S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. USA 100 9 (2003) 5473-5478
30. Teismann P., Vila M., Choi D.K., Tieu K., Wu D.C., Jackson-Lewis V., and Przedborski S. COX-2 and neurodegeneration in Parkinson's disease. Ann. NY Acad. Sci. 991 (2003) 272-277
31. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res. 830 2 (1999) 226-236